Zamisulf Tablet (Doxylamine Succinate)
Doxylamine Succinate 25mg
Tablet · OTC medication
Taegeuk Pharmaceutical Co., Ltd.
MFDS item code 199901052 · Notified 1999.07.02
This product's status changed to Expired on 2023.10.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Adjunctive treatment for insomnia and sedative effects
This medication is used for adjunctive treatment of insomnia and has sedative effects. It helps patients sleep and alleviates tension.
Adults: As Doxylamine Succinate, take 25mg orally once a day, 30 minutes before sleep. Adjust dosage based on age and symptoms.
This medication should not be taken by individuals with respiratory diseases such as emphysema, chronic bronchitis, or asthma. It is also advisable for patients with glaucoma or benign prostatic hyperplasia not to use this drug. Nursing women and children under the age of 15 should not take this medication. Since this medication contains lactose, individuals with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take it. During the course of this medication, it is important not to take other drugs such as imipramine-type antidepressants, antiparkinsonian agents, or disopyramide together, as this may worsen side effects such as urinary retention or constipation. Moreover, it is critical not to combine this medication with other drugs or to take it for more than 2 weeks without consulting a doctor or pharmacist. This medication can have strong sedative effects, so caution should be exercised when performing hazardous tasks such as operating heavy machinery or driving vehicles. It should not be taken after or during alcohol consumption. Individuals who are pregnant or may become pregnant should consult a doctor or pharmacist before taking this medication. While taking this medication, anticholinergic effects may cause symptoms such as dry mouth and constipation. Drowsiness may occur, so it is advisable to take this medication mainly before bedtime. If severe drowsiness occurs during the day, it may be necessary to reduce the dosage. Finally, this medication should be kept out of reach of children, and if removed from the original container and stored in another, there is a risk of degradation or misuse, so it should always be kept in the original container with the lid tightly closed.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a sealed container that is shielded from light. Additionally, it is important to keep it at temperatures between 1 to 30 degrees Celsius to maintain its effectiveness.
White or pale yellow round tablets
10 tablets (1 tablet/pack * 10)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Doxylamine Succinate 25mg
Tablet · OTC medication
Taegeuk Pharmaceutical Co., Ltd.

Doxylamine Succinate 25mg
Tablet · OTC medication
CMG Pharmaceutical Co., Ltd.

Doxylamine Succinate 25mg
Tablet · OTC medication
GL Pharma Co., Ltd.

Doxylamine Succinate 25mg
Tablet · OTC medication
Aliko Pharmaceutical Co., Ltd.
Doxylamine Succinate 25mg
Tablet · OTC medication
Samik Pharmaceutical Co., Ltd.

Doxylamine Succinate 25mg
Tablet · OTC medication
HanKook Pavis Pharmaceutical Co., Ltd.

Doxylamine Succinate 25mg
Tablet · OTC medication
IlYang Pharmaceutical Co., Ltd.
Doxylamine Succinate 25mg
OTC medication
CL Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.